Laddar...

Killing of Borrelia burgdorferi by Antibody Elicited by OspA Vaccine Is Inefficient in the Absence of Complement

A Lyme disease vaccine, based on the Borrelia burgdorferi lipoprotein OspA, has recently undergone phase III trials in humans. The results of one of these trials indicate that vaccine efficacy positively correlates with anti-OspA antibody titer. Spirochete killing within the tick vector midgut, upon...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Nowling, Jena M., Philipp, Mario T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 1999
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC96334/
https://ncbi.nlm.nih.gov/pubmed/9864253
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!